These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3732629)

  • 1. Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture.
    Sadler TW; Phillips LS; Balkan W; Goldstein S
    Diabetes; 1986 Aug; 35(8):861-5. PubMed ID: 3732629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for multifactorial origin of diabetes-induced embryopathies.
    Sadler TW; Hunter ES; Wynn RE; Phillips LS
    Diabetes; 1989 Jan; 38(1):70-4. PubMed ID: 2909414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor.
    Hunter ES; Phillips LS; Goldstein S; Sadler TW
    Teratology; 1991 Apr; 43(4):331-40. PubMed ID: 2048042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of maternal diabetes on embryogenesis.
    Sadler TW; Hunter ES; Balkan W; Horton WE
    Am J Perinatol; 1988 Oct; 5(4):319-26. PubMed ID: 3166639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies.
    Ornoy A; Zaken V; Kohen R
    Teratology; 1999 Dec; 60(6):376-86. PubMed ID: 10590399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes in pregnancy: experimental aspects.
    Giavini E
    Ann Ist Super Sanita; 1993; 29(1):27-34. PubMed ID: 8129268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of maternal diabetes on early embryogenesis. The role of insulin and insulin therapy.
    Sadler TW; Horton WE
    Diabetes; 1983 Nov; 32(11):1070-4. PubMed ID: 6357905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid.
    Goldman AS; Baker L; Piddington R; Marx B; Herold R; Egler J
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8227-31. PubMed ID: 3934670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of rat embryos in culture media containing different concentrations of normal and diabetic rat serum.
    Styrud J; Eriksson UJ
    Teratology; 1992 Nov; 46(5):473-83. PubMed ID: 1462252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture in vitro as a means of analysing the effect of maternal diabetes on embryonic development in rats.
    Deuchar EM
    Ciba Found Symp; 1978 Mar 30-Apr 1; (63):181-97. PubMed ID: 256541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats.
    Wentzel P; Eriksson UJ
    Eur J Endocrinol; 1996 Apr; 134(4):459-66. PubMed ID: 8640298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
    Khandelwal M; Reece EA; Wu YK; Borenstein M
    Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGE2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos.
    Goto MP; Goldman AS; Uhing MR
    Diabetes; 1992 Dec; 41(12):1644-50. PubMed ID: 1446806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions.
    Weksler-Zangen S; Yaffe P; Ornoy A
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):429-37. PubMed ID: 12962287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro development of rat embryos obtained from diabetic mothers.
    Menegola E; Prati M; Broccia ML; Ricolfi R; Giavini E
    Experientia; 1995 Apr; 51(4):394-7. PubMed ID: 7729505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal diabetes causes developmental delay and death in early-somite mouse embryos.
    Zhao J; Hakvoort TBM; Ruijter JM; Jongejan A; Koster J; Swagemakers SMA; Sokolovic A; Lamers WH
    Sci Rep; 2017 Sep; 7(1):11714. PubMed ID: 28916763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal diabetes induces increased expression of extracellular matrix components in rat embryos.
    Cagliero E; Forsberg H; Sala R; Lorenzi M; Eriksson UJ
    Diabetes; 1993 Jul; 42(7):975-80. PubMed ID: 7685721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatomedin inhibitors from human serum produce abnormalities in mouse embryos in culture.
    Balkan W; Rooman RP; Hurst-Evans A; Phillips LS; Goldstein S; Du Caju MV; Sadler TW
    Teratology; 1988 Jul; 38(1):79-86. PubMed ID: 3175944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of somatomedin inhibitors in the production of diabetic embryopathies.
    Balkan W; Phillips LS; Goldstein S; Sadler TW
    Teratology; 1988 Mar; 37(3):271-82. PubMed ID: 3368881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period.
    Trocino RA; Akazawa S; Takino H; Takao Y; Matsumoto K; Maeda Y; Okuno S; Nagataki S
    Endocrinology; 1994 Feb; 134(2):869-78. PubMed ID: 8299581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.